PTC Therapeutics Logo

Email this page: News Release

European Commission Ratifies Positive CHMP Opinion for the Renewal of Translarna™ Marketing Authorization for the Treatment of Nonsense Mutation Duchenne Muscular Dystrophy

For security reasons, registration is required before you can use this feature.
* Indicates required field